Oruka Therapeutics, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2017 | $-4.3M | $-4.3M | — | $101.0K |
| Jun 2017 | $-5.0M | $-5.0M | — | — |
| Sep 2017 | $-4.0M | $-4.0M | — | — |
| Mar 2018 | $-3.1M | $-3.1M | $1.0K | $97.0K |
| Jun 2018 | $-2.3M | $-2.3M | $0 | — |
| Sep 2018 | $-1.6M | $-1.6M | $3.0K | — |
| Mar 2019 | $-1.6M | $-1.6M | — | $50.0K |
| Jun 2019 | $-1.2M | $-1.2M | — | — |
| Sep 2019 | $-887.0K | $-887.0K | — | — |
| Mar 2020 | $-1.7M | $-1.7M | $3.0K | $16.0K |
| Jun 2020 | $-1.0M | $-1.0M | $3.0K | — |
| Sep 2020 | $-2.0M | $-2.0M | $0 | — |
| Mar 2021 | $-5.2M | $-5.2M | $6.0K | $141.0K |
| Jun 2021 | $-3.7M | $-3.7M | $16.0K | — |
| Sep 2021 | $-4.9M | $-4.9M | $14.0K | — |
| Mar 2022 | $-4.3M | $-4.3M | $2.0K | $167.0K |
| Jun 2022 | $-2.6M | $-2.6M | $0 | — |
| Sep 2022 | $-2.5M | $-2.5M | $0 | — |
| Mar 2023 | $-1.6M | $-1.6M | — | $204.0K |
| Jun 2023 | $-694.0K | $-694.0K | — | — |
| Sep 2023 | $-1.7M | $-1.7M | — | — |
| Mar 2024 | $-1.5M | $-1.5M | — | $114.0K |
| Jun 2024 | $-2.6M | $-2.6M | — | — |
| Mar 2025 | $-20.9M | $-20.9M | $13.0K | $4.9M |
| Jun 2025 | $-23.1M | $-23.2M | $34.0K | — |
| Sep 2025 | $-21.6M | $-21.7M | $99.0K | — |
| Mar 2026 | $-23.6M | $-23.7M | $73.0K | $7.0M |
| Jun 2026 | $-33.1M | $-33.1M | $0 | — |